SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-19-000967
Filing Date
2019-12-13
Accepted
2019-12-13 16:32:17
Documents
2
Group Members
ORBIMED CAPITAL GP IV LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss160411_sc13ga.htm SC 13G/A 65112
2 JOINT FILING AGREEMENT ss160411_ex99a.htm EX-99.A 7468
  Complete submission text file 0000947871-19-000967.txt   74121
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Subject) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90643 | Film No.: 191284968
SIC: 2834 Pharmaceutical Preparations